Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Canopy Rivers Inc. (V:RIV)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for RIV within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jan 17, 2020 06:00 ET
Rivers Rundown: Canopy Rivers Portfolio Companies Eyeing Retail Growth, Expanded U.S. Operations
Canopy Rivers provides update on High Beauty, TerrAscend, YSS, and JWC
Read full article
Jan 08, 2020 06:00 ET
Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant
BioLumic partners with JWC and Helius Therapeutics for cannabis research program
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
--
10.54
8.90
Price to Book - most recent quarter
0.76
1.67
2.30
Price to Cash Flow per share - TTM
--
5.35
9.86
Price to Free Cash Flow per share - TTM
--
1.85
17.13
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Aug 31, 2019351,615190,286
Aug 15, 2019161,32925,263
Jul 31, 2019136,066-84,452
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Canopy Rivers Inc, formerly Aim2 Ventures Inc, is a Canada-based investment and operating platform structured to pursue opportunities in the emerging global cannabis sector. Its portfolio of companies brings product, segment, geographic and investment structure diversification. The Company looks to invest in all segments of the cannabis value chain and aims to partner with management teams. Investments take the form of production-linked royalties, secured debt, newly formed joint ventures and a variety of equity and equity-linked instruments. The Company works collaboratively with Canopy Growth to identify strategic counterparties seeking financial and operating support and affiliation with the Canopy Growth group of companies.

See business summary

Twitter

Search (past week) for $RIV.CA RIV.V